Cryopyrin-Associated Periodic Syndromes Clinical Trials in North York, Ontario

Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)